Twu NF

No ORCID on file · 5 papers in corpus
article 2016
Low-dose add-back therapy during postoperative GnRH agonist treatment
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2015.04.004

OBJECTIVE: Low-dose add-back therapy during postoperative GnRH agonist treatment could lower the risk of add-back-induced endometriosis recurrence and reduce treatment dropout compared with a regular dose. However, the effect of low-dose ad…

article 2014
Oestrogen‐induced angiogenesis promotes adenomyosis by activating the Slug‐VEGF axis in endometrial epithelial cells
Journal of cellular and molecular medicine ·doi:10.1111/jcmm.12300

Adenomyosis is an oestrogen-dependent disease characterized by the invasion of endometrial epithelial cells into the myometrium of uterus, and angiogenesis is thought to be required for the implantation of endometrial glandular tissues duri…

case-report 2012
A challenge in the management of a patient with ovarian cancer associated with extensive endometriosis
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2012.04.035
other 2010
Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis
The Journal of Pathology ·doi:10.1002/path.2761

Adenomyosis is an oestrogen-dependent disease caused by a downward extension of the endometrium into the uterine myometrium. Epithelial-mesenchymal transition (EMT) endows cells with migratory and invasive properties and can be induced by o…

article 2006
Adenomyosis and risk of preterm delivery
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/j.1471-0528.2006.01186.x

OBJECTIVE: To evaluate the risk of preterm delivery in patients with adenomyosis. DESIGN: A 1:2 nested case-control study. SETTING: Tertiary-care institution. POPULATION: A base cohort population of 2138 pregnant women who attended routine …